http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111965239-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a387c8d6e1f0eab5fe83d8e7722e01f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-64
filingDate 2019-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4649c22f48ae568388639320bc7c6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adb4fe96f2602206b7aad384cb559fce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07089a6282afd5c7ae29dd27e8895d0f
publicationDate 2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111965239-A
titleOfInvention Products, applications and methods for gastric cancer related screening and assessment
abstract The present invention proposes a product, application and method for gastric cancer (Gastric Carcinoma, GC) related screening and evaluation. The present invention uses the body fluid samples of gastric cancer patients and healthy people to mix with nanosphere materials, and is desorbed and ionized by matrix-assisted laser. Time-of-flight mass spectrometry (MALDI‑TOF‑MS) collects information on metabolic molecules in relevant body fluids, and uses artificial intelligence classification algorithms to distinguish differences in metabolic molecular profiles between healthy and gastric cancer patients, and to classify the differences with high accuracy , high specificity and high sensitivity, or become a tool for gastric cancer-related screening and evaluation.
priorityDate 2019-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689

Total number of triples: 15.